Glenmark Pharmaceuticals
GLENMARK.NS
S$27.29
Share price
2.63%
Change (1 day)
26.12%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$1.06 Billion
According to Glenmark Pharmaceuticals 's latest financial reports the company's total liabilities are S$1.06 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Glenmark Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-03-31 | S$1.05 B | -31.8% |
| 2023-03-31 | S$1.54 B | 13.13% |
| 2022-03-31 | S$1.36 B | -13.12% |
| 2021-03-31 | S$1.57 B | -3.29% |
| 2020-03-31 | S$1.62 B | 8.23% |
| 2019-03-31 | S$1.49 B | 0.22% |
| 2018-03-31 | S$1.49 B | -4.43% |
| 2017-03-31 | S$1.56 B | 17.14% |
| 2016-03-31 | S$1.33 B | -9.02% |
| 2015-03-31 | S$1.46 B | 24.06% |
| 2014-03-31 | S$1.18 B | 18.19% |
| 2013-03-31 | S$1.00 B | 17.3% |
| 2012-03-31 | S$0.85 B | -0.26% |
| 2011-03-31 | S$0.85 B | 9.59% |
| 2010-03-31 | S$0.78 B | -0.93% |
| 2009-03-31 | S$0.78 B | 60.74% |
| 2008-03-31 | S$0.49 B | 11.19% |
| 2007-03-31 | S$0.44 B | 26.93% |
| 2006-03-31 | S$0.34 B | 55.9% |
| 2005-03-31 | S$0.22 B | 166.22% |
| 2004-03-31 | S$83.79 M |